Concepedia

Author

Christoph Gerdes

Bayer (Germany)ORCID

Also Known As

C Gerdes, C. Gerdes, Christoph Gerdes, Gerdes, Christoph

46

Publications

535

Citations

13

H-Index

12

Concepts

All Affiliations

Bayer (Germany)Medizinische Hochschule HannoverBayer (Japan)
CG

About

Christoph Gerdes is an author at Bayer (Germany) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

96

2

Pharmacology

5

5

96

3

Drug Discovery

3

3

62

4

Biochemistry

1

1

17

5

Drug Development

1

1

17

Christoph Gerdes

×

12

Publications

428

Citations

12

H-Index

YearCitations

Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa

Stefan Heitmeier, Mayken Visser, Adrian Tersteegen,

Journal of Thrombosis and Haemostasis

2022

81

Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran

Peter Ellinghaus, Elisabeth Perzborn, Peter Hauenschild,

Thrombosis Research

2016

71

A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosol

Christoph Gerdes, Natalia Waal, Thomas Offner,

Nature Communications

2020

50

Comparison of the Effects of the Thrombin Inhibitor r-Hirudin in Four Animal Models of Neointima Formation After Arterial Injury

Christoph Gerdes, Verona Faber-Steinfeld, Özkan Yalkinoglu,

Arteriosclerosis Thrombosis and Vascular Biology

1996

38

Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism – results from clinical observation studies

Marina Panova‐Noeva, B. Wagner, Markus Nagler,

EBioMedicine

2020

36

Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow

Jevgenia Zilberman‐Rudenko, Asako Itakura, Chantal P Wiesenekker,

Arteriosclerosis Thrombosis and Vascular Biology

2016

31

Biphenyls as potent vitronectin receptor antagonists

Klaus Urbahns, Michael Härter, Markus Albers,

Bioorganic & Medicinal Chemistry Letters

2002

25

Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders

Susanne Roehrig, Jens Ackerstaff, Eloísa Jiménez Núñez,

Journal of Medicinal Chemistry

2023

25

Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureas

Klaus Urbahns, Michael Härter, Andrea Vaupel,

Bioorganic & Medicinal Chemistry Letters

2003

20

Increase of serotonin in plasma during onset of halothane-induced malignant hyperthermia in pigs

Christoph Gerdes, Angelika Richter, Roger Annies,

European Journal of Pharmacology

1992

19

Page 1